Filana Therapeutics, Inc. Fair Value, Assets, Level 2 to Level 1 Transfers, Amount
Filana Therapeutics, Inc. (FLNA) had Fair Value, Assets, Level 2 to Level 1 Transfers, Amount of $0 as of 2018-09-30, per its 10-Q filed 2018-10-30.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount · last filed 2018-10-30
- 2018-09-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2018-06-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2018-03-31: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
- 2017-06-30: Fair Value, Assets, Level 2 to Level 1 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount |
|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-10-30 |
| 2018-06-30 | $0.00 10-Q · filed 2018-07-26 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 |
| 2016-09-30 | $0.00 10-Q · filed 2016-10-26 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 |
| 2016-03-31 | $0.00 10-Q · filed 2017-04-26 |
| 2015-09-30 | $0.00 10-Q · filed 2016-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |